(S)-3,5-Difluoro-α-methylbenzylamine hydrochloride is a chiral amine derivative characterized by a 3,5-difluorophenyl group attached to a chiral center bearing an amino group and a methyl group. It is supplied as a hydrochloride salt, which enhances its stability and handling properties. This compound is primarily utilized as a key chiral building block in pharmaceutical research and development. Its structure, featuring both a chiral center and a difluorinated aromatic ring, makes it a valuable intermediate for the synthesis of active pharmaceutical ingredients (APIs), particularly those targeting the central nervous system (CNS) or requiring specific stereochemistry for biological activity. The fluorine atoms are often introduced to modulate the lipophilicity, metabolic stability, and binding affinity of the final drug molecule. As a chiral amine, it serves as a versatile synthon in asymmetric synthesis. Its applications extend beyond specific drug candidates to general medicinal chemistry, where it is used to explore structure-activity relationships (SAR) in the design of novel therapeutic agents.